What the English source shows.
- Evidence group
- In vivo animal studies
- Journal
- ANTIOXIDANTS (BASEL) 2014 DEC 12;3(4) :843-65
- English PDF
- Page 97
Abstract focus
Background: Depletion of the endogenous antioxidant, glutathione (GSH), underlies progression of the devastating neurodegenerative disease, amyotrophic lateral sclerosis (ALS). Thus, strategies aimed at elevating GSH may yield new therapeutics for ALS.
Context from Dr. Gutman’s comments
ALS (Amyotrophic Lateral Sclerosis) is also known as ‘Lou Gehrig’s Disease’, a devastating neurodegenerative process that degrades muscle function and leads to eventual paralysis. Mice suffering from a similar disease are used in the laboratory to explore possible treatments for humans.
How to use this study responsibly
- Read it according to its evidence group, not as a universal product promise.
- Use the English PDF to verify the abstract and commentary directly.
- For medical conditions, treatment, pregnancy, breastfeeding or medication, speak with a qualified healthcare professional.